BIOLASE Technology, Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】BIOLASE Technology, Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 11
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of Markets/Categories Covered 13
3.1 Dental Devices 13
3.1.1 Dental Lasers 13
3.1.2 Dental Radiology Equipment 13
4 Company Snapshot 14
4.1 Key Facts 14
4.2 Company Overview 14
4.3 Financial Performance 14
4.4 SWOT Snapshot 14
5 Business Description 15
5.1 Business Overview 15
5.2 Advanced Dental, Cosmetic and Surgical Lasers and Related Products 15
5.2.1 Overview 15
5.2.2 Financials 15
5.2.3 Market View 15
5.3 Major Products and Services 16
5.3.1 Overview 16
6 History 17
7 SWOT Analysis 21
7.1 Overview 21
7.2 BIOLASE Technology, Inc. Strengths 22
7.2.1 Proprietary YSGG Laser Technology 22
7.2.2 Engineering and Product Development 22
7.2.3 Leading Market Position 22
7.3 BIOLASE Technology, Inc. Weaknesses 23
7.3.1 Geographically Concentrated Revenues 23
7.3.2 High Trade Receivables 23
7.4 BIOLASE Technology, Inc. Opportunities 23
7.4.1 Growing Aged Population 23
7.4.2 New Product Launches 23
7.4.3 Increasing Demand for Dental Services 23
7.4.4 Formation of BIOLASE Imaging 24
7.4.5 Strategic Initiatives 24
7.5 BIOLASE Technology, Inc. Threats 24
7.5.1 Rapid Technological Changes 24
7.5.2 Competitive Atmosphere 24
7.5.3 Stringent Government Regulations 25
8 Competitors 26
9 Competitive Landscape 27
9.1 Dental Devices (Dental Lasers), Global, Market Share (%), 2011 27
9.2 BIOLASE Technology, Inc., Dental Devices (Dental Lasers), by Region, Market Share (2011) 29
9.3 BIOLASE Technology, Inc., Dental Devices (Dental Lasers), by Country, Market Share (2011) 30
9.4 Dental Devices (Dental Radiology Equipment), Global, Market Share (%), 2011 32
9.5 BIOLASE Technology, Inc., Dental Devices (Dental Radiology Equipment), by Region, Market Share (2011) 34
9.6 BIOLASE Technology, Inc., Dental Devices (Dental Radiology Equipment), by Country, Market Share (2011) 35
9.7 BIOLASE Technology, Inc., Dental Devices, Global, Category Revenue Share (2011) 36
9.8 BIOLASE Technology, Inc., Asia-Pacific, Category Revenue Share (2011) 38
9.8.1 BIOLASE Technology, Inc., Australia, Category Revenue Share (2011) 38
9.8.2 BIOLASE Technology, Inc., China, Category Revenue Share (2011) 38
9.8.3 BIOLASE Technology, Inc., India, Category Revenue Share (2011) 38
9.8.4 BIOLASE Technology, Inc., Japan, Category Revenue Share (2011) 39
9.8.5 BIOLASE Technology, Inc., Other Asia-Pacific, Category Revenue Share (2011) 39
9.9 BIOLASE Technology, Inc., Europe, Category Revenue Share (2011) 40
9.9.1 BIOLASE Technology, Inc., France, Category Revenue Share (2011) 40
9.9.2 BIOLASE Technology, Inc., Germany, Category Revenue Share (2011) 40
9.9.3 BIOLASE Technology, Inc., Italy, Category Revenue Share (2011) 40
9.9.4 BIOLASE Technology, Inc., Spain, Category Revenue Share (2011) 41
9.9.5 BIOLASE Technology, Inc., United Kingdom, Category Revenue Share (2011) 41
9.9.6 BIOLASE Technology, Inc., Other Europe, Category Revenue Share (2011) 41
9.10 BIOLASE Technology, Inc., Middle East and Africa, Category Revenue Share (2011) 42
9.11 BIOLASE Technology, Inc., North America, Category Revenue Share (2011) 43
9.11.1 BIOLASE Technology, Inc., Canada, Category Revenue Share (2011) 45
9.11.2 BIOLASE Technology, Inc., United States, Category Revenue Share (2011) 47
9.12 BIOLASE Technology, Inc., South and Central America, Category Revenue Share (2011) 49
9.12.1 BIOLASE Technology, Inc., Brazil, Category Revenue Share (2011) 49
9.12.2 BIOLASE Technology, Inc., Other South and Central America, Category Revenue Share (2011) 49
10 Key Employees 50
11 Key Employee Biographies 51
12 Company Statement 52
13 Locations And Subsidiaries 56
13.1 Head Office 56
13.2 Other Locations & Subsidiaries 56
14 Financial Deals Landscape 58
14.1 BIOLASE Technology, Inc., Deals Volume Summary, 2007 to 2012 58
15 BIOLASE Technology, Inc., Deals Summary By Region, 2007 to 2012 59
16 BIOLASE Technology, Inc. Detailed Deal Summary 61
16.1 Asset Purchase 61
16.1.1 BIOLASE Technology Acquires 180 Waterlase MD Turbo Laser Systems From Henry Schein 61
16.2 Partnerships 63
16.2.1 BIOLASE Technology Enters Into Licensing Agreement With The Procter & Gamble Company 63
16.2.2 BIOLASE Technology Expands Licensing Agreement With Henry Schein 64
16.2.3 Biolase Enters Into Distribution Agreement With 3Shape For TRIOS 65
16.2.4 BIOLASE Enters Into Co-Marketing Agreement With Cefla Dental 66
16.2.5 BIOLASE Enters Into Distribution Agreements With Shanghai Haopu, E-Maxdent And Advanced Medical 67
16.3 Equity Offering 68
16.3.1 BIOLASE Technology Completes Private Placement Of Common Stock For $8.9 Million 68
16.3.2 BIOLASE Technology Announces Private Placement Of 3,000,000 Shares 69
16.3.3 BIOLASE Technology Announces Registered Direct Offering For $1.8 Million 70
16.4 Asset Transactions 71
16.4.1 Biolase Sells 159 Waterlase MD Turbo Laser Systems 71
17 Recent Developments 72
17.1 Strategy And Business Planning 72
17.1.1 Jun 06, 2011: BIOLASE Opens Company Offices In China And India 72
17.1.2 Apr 07, 2011: BIOLASE To Adopt Direct And Multi-Distributor Sales Model In Germany 73
17.1.3 Feb 24, 2011: BIOLASE Forms New Imaging Division 73
17.1.4 Dec 06, 2010: BIOLASE Opens Sales And Support Subsidiary In South Korea For Asian Distributors 74
17.1.5 Mar 05, 2009: BIOLASE Plans To Reduce Corporate Cost Structure 75
17.1.6 Dec 02, 2008: BIOLASE Reduces Quarterly Fixed Costs By $2 Million 75
17.2 Financial Announcements 75
17.2.1 Nov 05, 2012: Biolase Reports Revenue Of $13.7m In Q3 2012 75
17.2.2 Aug 08, 2012: Biolase Reports Revenue Of $12.2m In Q2 2012 77
17.2.3 May 09, 2012: Biolase Reports Revenue Of $12.3m In Q1 2012 78
17.2.4 Mar 08, 2012: BIOLASE Reports Revenue Of $48.9m In 2011 79
17.2.5 Nov 07, 2011: BIOLASE Reports Revenues Of $13.1m In Q3 2011 81
17.2.6 Aug 10, 2011: BIOLASE Reports Net Revenue Of $12.1m In Q2 2011 82
17.2.7 Jul 13, 2011: BIOLASE Reports Preliminary Q2 2011 Results 83
17.2.8 May 09, 2011: BIOLASE Reports Net Revenue Of $10.6m In Q1 2011 84
17.2.9 Apr 06, 2011: BIOLASE Reports Preliminary Q1 2011 Results 85
17.2.10 Mar 10, 2011: BIOLASE Reports Net Revenue Of $26.2m In 2010 86
17.2.11 Jan 20, 2011: BIOLASE Reports Preliminary Q4 2010 Results 86
17.2.12 Nov 02, 2010: BIOLASE Reports Net Loss Of $2.73 Million In Q3 2010 87
17.2.13 Aug 17, 2010: BIOLASE Reports Net Revenues Of $5.89 Million In Q2 2010 87
17.2.14 May 17, 2010: BIOLASE Reports Net Loss Of $5.30 Million In Q1 2010 88
17.2.15 Mar 18, 2010: BIOLASE Reports Net Revenue Of $43.3 Million In 2009 88
17.2.16 Nov 05, 2009: BIOLASE Reports Net Revenue Of $12 Million In Q3 2009 90
17.2.17 Aug 06, 2009: BIOLASE Posts $2.3 Million Net Income In Q2 2009 91
17.2.18 Jul 07, 2009: BIOLASE Announces Preliminary Q2 2009 Results 91
17.2.19 May 07, 2009: BIOLASE Posts $4.7 Million Net Loss In Q1 2009 91
17.2.20 Mar 16, 2009: BIOLASE Reports 2008 Results 92
17.2.21 Feb 05, 2009: BIOLASE Reports Preliminary 2008 Results 93
17.2.22 Nov 05, 2008: BIOLASE Reports 3Q 2008 Results 93
17.2.23 Aug 07, 2008: BIOLASE Reports 2Q 2008 Results 94
17.2.24 May 07, 2008: BIOLASE Declares Q1 2008 Results 95
17.2.25 Mar 11, 2008: BIOLASE Declares Q4 2007 Results 96
17.2.26 Jan 07, 2008: Biolase Declares Preliminary Q4 2007 Results 97
17.2.27 Nov 06, 2007: BIOLASE Declares Q3 2007 Results 97
17.2.28 Nov 06, 2007: BIOLASE Reports Q3 2007 Results 98
17.2.29 Aug 07, 2007: BIOLASE Declares Q2 2007 Results 99
17.2.30 May 08, 2007: BIOLASE Declares Q1 2007 Results 99
17.2.31 Mar 14, 2007: BIOLASE Declares Q4 2006 Results 100
17.3 Research And Development 101
17.3.1 Jul 31, 2012: Biolase Signs Long-Term Collaboration Agreement With Professor Norbert Gutknecht And AALZ 101
17.4 Corporate Communications 102
17.4.1 Mar 08, 2012: BIOLASE Appoints William E Brown To Vice President, Sales & Marketing 102
17.4.2 Oct 19, 2011: BIOLASE CFO Frederick D Furry To Add COO Role 103
17.4.3 Oct 17, 2011: BIOLASE Promotes Richard Whipp To Vice President Of Operations 103
17.4.4 Aug 11, 2011: BIOLASE Names Ehab M Esmail As Vice President Global Regulatory, Quality And Clinical Affairs 104
17.4.5 Jul 06, 2011: BIOLASE Names Richard Whipp As Director, Operations 105
17.4.6 Nov 30, 2010: BIOLASE Appoints Frederick Furry As CFO 105
17.4.7 Nov 02, 2010: BIOLASE Appoints Gregory E. Lichtwardt To Board Of Directors 106
17.4.8 Oct 18, 2010: BIOLASE Announces Compliance With Nasdaq Minimum Stockholders’ Equity Requirement 106
17.4.9 Oct 04, 2010: BIOLASE Promotes Dmitri Boutoussov To CTO 107
17.4.10 Sep 30, 2010: BIOLASE Announces 30% Increase In Sales Force 107
17.4.11 Sep 30, 2010: BIOLASE Appoints Federico Pignatelli As CEO 108
17.4.12 Sep 27, 2010: BIOLASE Announces Extensive Restructuring 108
17.4.13 Aug 27, 2010: BIOLASE Names Federico Pignatelli As Executive Chairman 109
17.4.14 Aug 24, 2010: BIOLASE Receives Deficiency Letter From NASDAQ 109
17.4.15 Jul 19, 2010: BIOLASE Appoints Alex Arrow, Norman Nemoy To Board 109
17.4.16 Jul 13, 2010: BIOLASE Eliminates 20 Positions 110
17.4.17 Jul 13, 2010: BIOLASE Names Federico Pignatelli As Executive Vice Chairman 110
17.4.18 Jul 13, 2010: BIOLASE Announces Resignation Of Brett Scott As CFO 111
17.4.19 Oct 26, 2009: BIOLASE Appoints Gregory Waller To Its Board 111
17.4.20 Jul 14, 2009: BIOLASE Appoints Brett Scott As New CFO 111
17.4.21 Apr 15, 2009: BIOLASE Technology Receives Approval To Transfer To The NASDAQ Capital Market 112
17.4.22 Mar 26, 2009: BIOLASE Receives Deficiency Notice From NASDAQ 112
17.4.23 Mar 10, 2009: BIOLASE Appoints Interim CFO 113
17.4.24 Mar 05, 2009: BIOLASE Promotes David M. Mulder As New CEO 113
17.4.25 Oct 09, 2008: BIOLASE Appoints Vice President, International 114
17.4.26 Apr 30, 2008: BIOLASE Appoints New CFO 114
17.4.27 Feb 01, 2008: BIOLASE Appoints Interim CFO 114
17.4.28 Jan 07, 2008: Biolase Appoints Chief Executive Officer 115
17.4.29 Nov 06, 2007: BIOLASE Appoints Interim CEO 115
17.4.30 Nov 06, 2007: BIOLASE Appoints Interim CEO 115
17.4.31 Jun 06, 2007: BIOLASE Appoints New Board Member 115
17.5 Legal and Regulatory 116
17.5.1 Apr 30, 2012: Biolase Responds To Patent Action 116
17.5.2 Apr 25, 2012: Biolase Files Patent Infringement Lawsuit Against European Competitor 117
17.5.3 Jun 16, 2011: BIOLASE Announces Settlement With Philips And Discus 117
17.5.4 May 19, 2010: Discus Dental, Zap Lasers Drop Allegation Of Fraud Against BIOLASE 117
17.5.5 Apr 07, 2010: Discus Dental, Zap Lasers Files Lawsuit Against Biolase In California 118
17.5.6 Mar 26, 2009: BIOLASE Reaches Settlement Agreement With NLT 118
17.5.7 Sep 15, 2008: BIOLASE Files Counter Lawsuit Against NLT 119
17.5.8 Aug 20, 2008: NLT Files Federal Lawsuit Against BIOLASE For Anticompetitive Conduct 119
17.6 Government and Public Interest 120
17.6.1 Oct 25, 2011: BIOLASE To Present At 6th Singular Research Best of the Uncovereds Conference 120
17.7 Product News 120
17.7.1 Feb 06, 2013: Biolase Receives FDA Clearance For 940nm Diolase 10 Diode Soft Tissue Laser For Broad Spectrum Of Medical Procedures 120
17.7.2 Sep 06, 2012: Biolase Achieves Sales Milestone With 20,000th Laser Sold Worldwide 121
17.7.3 Jun 18, 2012: Biolase Waterlase iPlus All-Tissue Dental Laser System Wins Awards For High-Tech Innovation And Medical Design 121
17.7.4 May 04, 2012: Biolase Demonstrates EPIC 10 Diode Laser At Anaheim 2012, California 121
17.7.5 Sep 13, 2011: BIOLASE Receives Russian Approval To Sell iLase Portable Dental Laser System 122
17.7.6 Sep 13, 2011: BIOLASE Receives Russian Approval To Sell Waterlase iPlus All-Tissue Dental Laser System 122
17.7.7 Aug 29, 2011: BIOLASE Receives Canadian Approval To Sell Waterlase iPlus All-Tissue Dental Laser Systems 123
17.7.8 Jul 25, 2011: BIOLASE Reports First Orders For BIOLASE DaVinci Imaging Systems For Delivery In Q3 2011 123
17.7.9 Feb 28, 2011: BIOLASE Shows Waterlase iPlus All-Tissue Laser At 146th Chicago Dental Society Midwinter Meeting 124
17.7.10 Feb 03, 2011: BIOLASE Receives CE Mark Approval For Waterlase iPlus All-Tissue Laser 124
17.7.11 Feb 01, 2011: BIOLASE Introduces Waterlase iPlus All-Tissue Laser At Boston Yankee Dental Congress 36 125
17.7.12 Jan 20, 2011: BIOLASE Launches Dual-Wavelength Waterlase iPlus All-Tissue Laser 126
17.7.13 Jun 11, 2010: BIOLASE Receives Canadian Approval For iLase Personal Dental Laser System 127
17.7.14 Apr 14, 2010: BIOLASE Wins US Patent For ezlase And iLase Diode Lasers 127
17.7.15 Apr 06, 2010: BIOLASE To Present Water-Based Laser Technology For Eye Surgery At American Society Of Cataract And Refractive Surgery Symposium And Congress 127
17.7.16 Mar 16, 2010: BIOLASE Receives FDA 510(K) Approval For iLase Personal Laser 128
17.7.17 Feb 25, 2010: BIOLASE Introduces iLase Personal Laser For Dental 129
17.7.18 Feb 22, 2010: BIOLASE To Unveil New Dental Laser At Chicago Midwinter Dental Show 130
17.7.19 Dec 09, 2009: BIOLASE Receives FDA 510(K) Approval For Waterlase MD Laser To Treat Periodontitis 130
17.7.20 Nov 03, 2009: BIOLASE Technology Launches Diolase 10 Diode Laser For Therapeutic Applications 131
17.7.21 Apr 16, 2009: BIOLASE Technology Receives FDA 510(k) Clearance For Its ezlase Diode Laser For Pain Therapy & Relief 132
17.7.22 Dec 30, 2008: BIOLASE Announces National Broadcast Of First Laser Root Canal Procedure 133
17.7.23 Aug 19, 2008: BIOLASE Launches Software Upgrade For First Generation Waterlase Dental Laser Systems 133
17.7.24 Aug 19, 2008: BIOLASE Technology Inc. Launches Software Upgrade For First Generation Waterlase Dental Laser Systems 133
17.7.25 Apr 10, 2008: Biolase Announces Global Launch Of Endolase RFT Root Canal Therapy System For Waterlase MD Laser System 134
17.7.26 Mar 19, 2008: BIOLASE Announces FDA 510(k) Clearance Of Waterlase For Root Canal Disinfection 135
17.7.27 Mar 19, 2008: BIOLASE Announces FDA 510(k) Clearance Of Waterlase MD Laser System For Root Canal Disinfection 135
17.8 Product Approvals 136
17.8.1 Feb 06, 2013: Biolase Receives FDA Clearance For 940nm Diolase 10 Diode Soft Tissue Laser For Broad Spectrum Of Medical Procedures 136
17.8.2 Sep 13, 2011: BIOLASE Receives Russian Approval To Sell Waterlase iPlus All-Tissue Dental Laser System 137
17.8.3 Sep 13, 2011: BIOLASE Receives Russian Approval To Sell iLase Portable Dental Laser System 137
17.8.4 Aug 29, 2011: BIOLASE Receives Canadian Approval To Sell Waterlase iPlus All-Tissue Dental Laser Systems 137
17.8.5 Feb 03, 2011: BIOLASE Receives CE Mark Approval For Waterlase iPlus All-Tissue Laser 138
17.8.6 Jun 11, 2010: BIOLASE Receives Canadian Approval For iLase Personal Dental Laser System 138
17.8.7 Dec 09, 2009: BIOLASE Receives FDA 510(K) Approval For Waterlase MD Laser To Treat Periodontitis 139
17.8.8 Apr 16, 2009: BIOLASE Technology Receives FDA 510(k) Clearance For Its ezlase Diode Laser For Pain Therapy & Relief 140
17.8.9 Mar 19, 2008: BIOLASE Announces FDA 510(k) Clearance Of Waterlase MD Laser System For Root Canal Disinfection 141
17.9 Other Significant Developments 141
17.9.1 Jan 27, 2012: BIOLASE Signs Strategic Sales And Marketing Partnership With Seattle Study Club 141
17.9.2 Oct 13, 2011: BIOLASE Announces Laser Sales Exceed US Laser Sales In Third Quarter 141
17.9.3 Feb 28, 2011: BIOLASE Receives Orders For Dental Product Line 142
17.9.4 Sep 30, 2010: BIOLASE Announces 30% Increase In Sales Force 142
17.9.5 Sep 27, 2010: BIOLASE Announces Extensive Restructuring 143
17.9.6 Sep 27, 2010: BIOLASE Announces Non-Exclusive Distribution Agreement With Henry Schein 143
17.9.7 Mar 10, 2010: BIOLASE And Henry Schein Extend And Amend Licensing And Distribution Agreement 144
17.9.8 Sep 28, 2009: BIOLASE Announces Distribution Agreements In China 144
17.9.9 Mar 05, 2009: BIOLASE Renew Distribution Agreement With Henry Schein 145
17.9.10 Feb 05, 2009: BIOLASE Reveals Operational Restructuring 146
17.9.11 Mar 07, 2008: BIOLASE And Henry Schein Renew Distribution Agreement 147
18 Appendix 148
18.1 Research Methodology 149
18.2 Secondary Research 149
18.3 Primary Research 149
18.4 Models 150
18.5 Forecasts 150
18.6 Expert Panels 150
18.7 GlobalData Consulting 150
18.8 Currency Conversion 151
18.9 Contact Us 152
18.10 Disclaimer 152


【レポート販売概要】

■ タイトル:BIOLASE Technology, Inc.:市場シェア分析
■ 英文:BIOLASE Technology, Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160477
■ 調査対象地域:グローバル
  • 公共安全向けLTE通信(Public Safety LTE)の世界市場
    Considered as the de-facto standard for Public Safety broadband communications, LTE is rapidly gaining momentum within the Public Safety industry. As a result Public Safety agencies, vendors and service provider are heavily investing in Public Safety LTE, with commercial deployments in both the North America and the Middle East region. While initial investments appear promising there still remain …
  • LTE戦略、アプリケーションロードマップ及び4Gの展望分析
    The Long Term Evolution (LTE) standard for 4G provides significant capacity gains as well as true end-to-end Internet Protocol (IP) connectivity including voice over IP (VoIP) via voice over LTE (VoLTE). LTE is ushering in a new world of opportunities and challenges for every industry constituent including everything from new business models and industry participants to operational support systems …
  • モーション制御の世界市場:電子式駆動装置、アクチュエータ、ACドライブ、運動制御装置
    About Motion Control Motion control systems provide agility and flexibility to industrial processes by controlling the speed, position, and velocity of machines. They are used in discrete industries such as packaging and labeling, semiconductor, material handling, and automotive; process industries such as power, energy, oil and gas; and hybrid industries such as F&B, metal and mining, and life sc …
  • Canadian Oil Sands Limited社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Canadian Oil Sands Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
  • Alexander Energy Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Alexander Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Alexander Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
  • 世界の軍事用電気光学・赤外線市場(2014-2024):地域分析
    Synopsis This report offers detailed analysis of the global Military Electro Optical Infrared (EO/IR) market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Military Electro Optical Infrared (EO/IR) market. Summary "The Global Military Electro Optical Infrared (EO/IR) Market 2014-2024 - Countr …
  • 世界のナンバープレート自動認識市場調査レポート:Global Automatic Number Plate Recognition (ANPR) Market 2014-2018
    TechNavio's analysts forecast the Global Automatic Number Plate Recognition market to grow at a CAGR of 14.12 percent over the period 2013-2018. One of the key factors contributing to this market growth is growing demand for improved security. The Global Automatic Number Plate Recognition market has also been witnessing immense advancement in technology. However, the growing intrusion of privacy c …
  • テレラジオロジー(遠隔放射線診断)の世界市場2016-2020
    About the Global Teleradiology Market The healthcare industry is witnessing phenomenal changes owing to increased adoption of digital health platforms such as mobile health, telehealth, EMR, and other wireless technologies. Digital health platforms have become essential elements in every healthcare organization, as they enable remote monitoring of patients, increase healthcare delivery efficiencie …
  • 2014年戦略提言:世界の薬物乱用検査市場
    Complete report $8,500.  DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 318-page report from Venture Planning Group contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.  The report provi …
  • 世界のガリウム砒素(GaAs)デバイス市場2015
    The Global Gallium arsenide (GaAs) Devices Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Gallium arsenide (GaAs) Devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Gallium arsenide (GaAs) Devices market analysis is provided for the intern …
  • 民間航空機客室内装製品市場の世界市場2014-2018
    About Commercial Aircraft Cabin Interior The interior of an aircraft cabin consists of lights, IFEC, seats, windows, windshield, and others, including the galley and monument, and lavatory. The use of lights, upholstery, color combinations, and other value add-ons add to the overall look of an aircraft's interior. TechNavio's analysts forecast the Global Commercial Aircraft Cabin Interior market t …
  • 深部脳刺激療法(DBS)装置の世界市場2016-2020
    About Deep Brain Stimulation A neurostimulation system, also known as a neurostimulator, provides therapeutic activation or modulation in the nervous system at targeted anatomical sites. Deep brain stimulation (DBS) system, a type of neurostimulator, generates electrical stimulation to the targeted areas of the brain and regulates the electrical signals that are generated by the diseased brain cel …
  • 閉経後膣萎縮(PVA):世界市場(医薬品市場予測及び分析~2022)
    PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a considerable change between 2012 and 2022. This market has historically had a large untreated population due to: low diagnosis rates, safety issues with the exi …
  • Exxon Mobil Corporation:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Exxon Mobil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Exxon Mobil Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
  • 左心耳閉鎖術の世界市場2017-2021
    About Left Atrial Appendage Closure Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the disease do not function properly. Atrial fibrillation can cause chest pain, heart failure, or stroke. The doctor needs to identify the first detected event of atrial fibrillation in a patient. The oc …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。